Technology & Market Development Recent scientific and commercial initiatives include: New R&D programs targeting implantable and antipathogenic productsAn active technology pipeline focused on surgical-grade silicon nitride devicesPartnerships and licensing discussions with leading medical OEMsSINTX’s Salt Lake City facility remains only FDA-registered and ISO 13485 certified, silicon nitride ceramic manufacturer Improved Financial Position $6.5 million cash on hand as of March 31, 2025 – nearly doubling from $3.6 million at year-endRecent $5.0 million private placement in February 2025 supported strategic runway along with potential to raise an additional $5.0 million dollars from the exercise of warrants with an exercise price of $3.32 per share of common stockReduced operating cash burn from $2.7M in Q1 2024 to $1.3M in Q1 2025 due to cost optimization Operational Streamlining Sale of non-core subsidiary TA&T to Tethon CorporationWorkforce reduction and shut down of underperforming Armor subsidiaryInitiated negotiations to reduce long-term lease liabilities, particularly at the Armor facility These actions are expected to further unlock capital for high-return growth projects.
Salt Lake City, UT , May 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc.(NASDAQ: SINT), an advanced ceramics company pioneering medical and antipathogenic applications of silicon nitride (Si₃N₄), today provided a comprehensive update on its operational progress, strategic initiatives, and financial position for the first quarter ended March 31, 2025.
A discussion of other risks and uncertainties that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the SEC on March 19, 2025, and in SINTX’s other filings with the SEC.
The story "SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization " has 621 words across 25 sentences, which will take approximately 3 - 6 minutes for the average person to read.
Which news outlet covered this story?
The story "SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization " was covered 20 hours ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 133 news stories per day.
It's most recent story was published 8 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Negative, indicating that people regard this as "bad news".
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
